<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Chatterjee S</submitter><funding>Macquarie University</funding><funding>Royal Adelaide Hospital</funding><funding>Cancer Institute NSW</funding><funding>Australian Cystic Fibrosis Research Trust</funding><pagination>516</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7867038</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>10(3)</volume><pubmed_abstract>Bacteremia-i.e., the presence of pathogens in the blood stream-is associated with long-term morbidity and is a potential precursor condition to life-threatening sepsis. Timely detection of bacteremia is therefore critical to reduce patient mortality, but existing methods lack precision, speed, and sensitivity to effectively stratify bacteremic patients. Herein, we tested the potential of quantitative serum N-glycomics performed using porous graphitized carbon liquid chromatography tandem mass spectrometry to stratify bacteremic patients infected with Escherichia coli (n = 11), Staphylococcus aureus (n = 11), Pseudomonas aeruginosa (n = 5), and Streptococcus viridans (n = 5) from healthy donors (n = 39). In total, 62 N-glycan isomers spanning 41 glycan compositions primarily comprising comp</pubmed_abstract><journal>Journal of clinical medicine</journal><pubmed_title>Serum N-Glycomics Stratifies Bacteremic Patients Infected with Different Pathogens.</pubmed_title><pmcid>PMC7867038</pmcid><funding_grant_id>International Macquarie Research Excellence Scholarship</funding_grant_id><funding_grant_id>A.R Clarkson Scholarship</funding_grant_id><funding_grant_id>Mary Overton Early Career Fellowship</funding_grant_id><funding_grant_id>Postgraduate studentship award</funding_grant_id><funding_grant_id>Clinical Project Grant</funding_grant_id><funding_grant_id>Macquarie University Safety Net Grant</funding_grant_id><funding_grant_id>Early Career Fellowship</funding_grant_id><pubmed_authors>Tjondro HC</pubmed_authors><pubmed_authors>Kawahara R</pubmed_authors><pubmed_authors>Torpy DJ</pubmed_authors><pubmed_authors>Shaw DR</pubmed_authors><pubmed_authors>Thaysen-Andersen M</pubmed_authors><pubmed_authors>Nenke MA</pubmed_authors><pubmed_authors>Chatterjee S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Serum N-Glycomics Stratifies Bacteremic Patients Infected with Different Pathogens.</name><description>Bacteremia-i.e., the presence of pathogens in the blood stream-is associated with long-term morbidity and is a potential precursor condition to life-threatening sepsis. Timely detection of bacteremia is therefore critical to reduce patient mortality, but existing methods lack precision, speed, and sensitivity to effectively stratify bacteremic patients. Herein, we tested the potential of quantitative serum N-glycomics performed using porous graphitized carbon liquid chromatography tandem mass spectrometry to stratify bacteremic patients infected with Escherichia coli (n = 11), Staphylococcus aureus (n = 11), Pseudomonas aeruginosa (n = 5), and Streptococcus viridans (n = 5) from healthy donors (n = 39). In total, 62 N-glycan isomers spanning 41 glycan compositions primarily comprising comp</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Feb</publication><modification>2025-04-04T18:44:17.869Z</modification><creation>2021-02-21T07:24:15Z</creation></dates><accession>S-EPMC7867038</accession><cross_references><pubmed>33535571</pubmed><doi>10.3390/jcm10030516</doi></cross_references></HashMap>